Generic and specialty pharmaceuticals company Mylan NV yesterday agreed to pay $465 million to settle allegations of overcharging the US government on its Medicaid program for its EpiPen products

EpiPens in UK sold for 10% of US prices

30 Sep 2016

View details about the software product Informachine News Trackers

Latest articles

RBI raises ceiling for collateral-free agricultural loan from Rs1.6 lakh to Rs2 lakh

Govt launches ‘Jalvahak’ for regular cargo movement on inland waterways

US Fed cuts Federal funds rate by 0.25% despite high inflation

ABB to acquire power electronics business of Gamesa Electric in Spain

MoU between SIA-India and Ghana Space Science inked

Isro commences Gaganyaan-G1 launch campaign

India plans a Rs9,000-crore boost to EV battery production

Skoda-Volkswagen India faces Rs12,000-cr tax evasion charge

India’s wholesale price inflation slows to 1.89% in November